Inventor

CHENARD BERTRAND L

US62 patents

⚠️ This page may combine multiple inventors who share the name “CHENARD BERTRAND L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHENARD BERTRAND L

PFIZER

Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist

Pharmaceutical combinations for the treatment of stroke and traumatic brain injury

Pharmaceutical combinations for the treatment of stroke and traumatic brain injury

Quinazolin-4-one AMPA antagonists

Bicyclo[3.1.0]hexanes and related compounds

2-piperidino-1-alkanol derivatives as neuroprotective agents

Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols

Neuroprotective indolone and related derivatives

Neuroprotective indolone and related derivatives

2-piperidino-1-alkanol derivatives as antiischemic agents

Nortropyl-1-alkanol derivatives as antiischemic agents

Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones

Combinations for the treatment of parkinsonism containing selective NMDA antagonists

Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy

Quinazoline-4-one AMPA antagonists

2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones

Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives

Thieno-pyrimidin-4-one AMPA antagonists

2,3 disubstituded-4(3H)-quinazolinones

2-pyrrolidino-1-alkanol derivatives as antiischemic agents

Intermediates for 2-piperidino-1-alkanols

Aryl and heteroaryl alkoxynaphthalene derivatives

Neuroprotective compounds

Intermediates for 2-piperidino-1-alkanol derivatives

Prodrug esters of phenolic 2-piperidino-1-alkanols

NMDA NR2B antagonists for treatment

NEUROGEN CORP

3-substituted-6-aryl pyridines

Substituted quinolin-4-ylamine analogues

2-phenoxy pyrimidinone analogues

Substituted 1-benzyl-4-substituted piperazine analogues

Aryl imidazoles and related compounds as C5a receptor modulators

Substituted biaryl piperazinyl-pyridine analogues

Substituted biaryl quinolin-4-ylamine analogues

HYDRA BIOSCIENCES INC

Substituted xanthines and methods of use thereof

Inhibiting the transient receptor potential A1 ion channel

Substituted xanthines and methods of use thereof

Substituted xanthines and methods of use thereof

DU PONT

Preparation of anhydrous organic acid salts

8-substituted pyrazolopentathiepins and related compounds

Substituted benzopentathiepins, process therefor and intermediates

HYDRA BIOSCIENCES LLC

Substituted xanthines and methods of use thereof

Substituted xanthines and methods of use thereof

LILLY CO ELI

Inhibiting the transient receptor potential A1 ion channel

Inhibiting the transient receptor potential A1 ion channel

KAMARI PHARMA LTD

Compounds and compositions for use in treating skin disorders

Compounds and compositions for use in treating skin disorders

NOVARTIS INT PHARM LTD

3-substituted-6-aryl pyridines

EXITHERA PHARMACEUTICALS INC

Therapeutic compounds and compositions

EXLTHERA PHARMACEUTICALS INC

Therapeutic compounds and compositions

LUKE GEORGE P

Aryl imidazoles and related compounds as C5a receptor modulators